All cancer staging systems seek to identify clinical and pathological features that can predict outcome or guide therapy. In particular, a non-invasive method for the early detection of disseminating disease would be of great interest. We investigated the use of cytokeratin genes expression to detec
Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients
β Scribed by Reza Raeisossadati; Moein Farshchian; Azita Ganji; Alieza Tavassoli; Arash Velayati; Ezzat Dadkhah; Somaye Chavoshi; Mostafa Mehrabi Bahar; Bahram Memar; Mohammad Taghi Rajabi Mashhadi; Hossein Naseh; Mohammad Mahdi Forghanifard; Meysam Moghbeli; Omeed Moaven; Mohammad Reza Abbaszadegan
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 147 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0179-1958
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The detection of disseminated tumor cells in peripheral blood from colorectal cancer patients by RTβPCR could be an attractive method for selecting patients for adjuvant therapy. We here report on realβtime RTβPCR assays (LightCycler) to quantitate potential mRNA markers. We investigate
## Abstract To identify tumorβassociated antigens as putative targets for developing immunotherapies against prostate cancer, we investigated the ability of T cells derived from the peripheral blood lymphocytes of prostate cancer patients to recognize autologous tumor cells. The technical challenge
## Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer To the Editor: The presence of circulating tumor cells (CTC) in the peripheral blood of cancer patients has attracted a great deal of attention among invest